Oliver Rath

5.0k total citations · 1 hit paper
26 papers, 3.8k citations indexed

About

Oliver Rath is a scholar working on Molecular Biology, Cell Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Oliver Rath has authored 26 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Cell Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Oliver Rath's work include Melanoma and MAPK Pathways (14 papers), Microtubule and mitosis dynamics (10 papers) and Cancer Mechanisms and Therapy (5 papers). Oliver Rath is often cited by papers focused on Melanoma and MAPK Pathways (14 papers), Microtubule and mitosis dynamics (10 papers) and Cancer Mechanisms and Therapy (5 papers). Oliver Rath collaborates with scholars based in United Kingdom, South Korea and United States. Oliver Rath's co-authors include Walter Kölch, Amardeep S. Dhillon, Suzanne Hagan, Frank Kozielski, Kwang‐Hyun Cho, Sang‐Mok Choo, Sung‐Young Shin, Hung Yi Kristal Kaan, Man-Sun Kim and Frances Fee and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature reviews. Cancer.

In The Last Decade

Oliver Rath

26 papers receiving 3.8k citations

Hit Papers

MAP kinase signalling pathways in cancer 2007 2026 2013 2019 2007 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Rath United Kingdom 19 2.7k 850 679 553 436 26 3.8k
Amardeep S. Dhillon Australia 25 3.6k 1.3× 1.1k 1.4× 516 0.8× 740 1.3× 683 1.6× 44 4.9k
Michael H. Cardone United States 21 3.3k 1.2× 841 1.0× 555 0.8× 483 0.9× 373 0.9× 31 4.4k
Fumin Chang United States 17 2.3k 0.8× 964 1.1× 338 0.5× 527 1.0× 389 0.9× 26 3.5k
Evripidis Gavathiotis United States 38 4.5k 1.7× 780 0.9× 485 0.7× 414 0.7× 353 0.8× 75 5.8k
Joong Sup Shim Macao 33 3.2k 1.2× 994 1.2× 1.3k 2.0× 792 1.4× 233 0.5× 85 5.0k
Suzanne Hagan United Kingdom 20 2.4k 0.9× 808 1.0× 275 0.4× 538 1.0× 664 1.5× 46 4.1k
Maria Ruzzene Italy 41 4.5k 1.6× 1.1k 1.3× 665 1.0× 326 0.6× 366 0.8× 120 6.1k
Jörg Bäsecke Germany 22 3.0k 1.1× 1.2k 1.4× 266 0.4× 669 1.2× 460 1.1× 34 4.4k
John Brognard United States 25 3.7k 1.4× 1.0k 1.2× 332 0.5× 658 1.2× 358 0.8× 50 4.5k
Ping Chen China 31 2.1k 0.8× 838 1.0× 298 0.4× 728 1.3× 228 0.5× 125 3.3k

Countries citing papers authored by Oliver Rath

Since Specialization
Citations

This map shows the geographic impact of Oliver Rath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Rath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Rath more than expected).

Fields of papers citing papers by Oliver Rath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Rath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Rath. The network helps show where Oliver Rath may publish in the future.

Co-authorship network of co-authors of Oliver Rath

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Rath. A scholar is included among the top collaborators of Oliver Rath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Rath. Oliver Rath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Jiryeon, Oliver Rath, Julia Schueler, et al.. (2017). Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma. Translational Oncology. 10(3). 304–310. 3 indexed citations
2.
Kim, Sun Young, Su Jin Lee, Seung Tae Kim, et al.. (2016). BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells. Translational Oncology. 9(3). 197–202. 10 indexed citations
3.
Talapatra, Sandeep K., et al.. (2016). Depsidones from Lichens as Natural Product Inhibitors of M-Phase Phosphoprotein 1, a Human Kinesin Required for Cytokinesis. Journal of Natural Products. 79(6). 1576–1585. 16 indexed citations
4.
Good, James A. D., Fang Wang, Oliver Rath, et al.. (2013). Optimized S-Trityl-l-cysteine-Based Inhibitors of Kinesin Spindle Protein with Potent in Vivo Antitumor Activity in Lung Cancer Xenograft Models. Journal of Medicinal Chemistry. 56(5). 1878–1893. 35 indexed citations
5.
Rath, Oliver & Frank Kozielski. (2012). Kinesins and cancer. Nature reviews. Cancer. 12(8). 527–539. 384 indexed citations
6.
Zebisch, Armin, Albert Wölfler, Isabella Fried, et al.. (2012). Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia. Leukemia. 26(8). 1842–1849. 25 indexed citations
7.
Abualhasan, Murad, James A. D. Good, Kitiyaporn Wittayanarakul, et al.. (2012). Doing the methylene shuffle – Further insights into the inhibition of mitotic kinesin Eg5 with S-trityl l-cysteine. European Journal of Medicinal Chemistry. 54. 483–498. 19 indexed citations
8.
Wang, Fang, James A. D. Good, Oliver Rath, et al.. (2012). Triphenylbutanamines: Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity. Journal of Medicinal Chemistry. 55(4). 1511–1525. 37 indexed citations
9.
Al‐Mulla, Fahd, Milad S. Bitar, May Al‐Maghrebi, et al.. (2011). Raf Kinase Inhibitor Protein RKIP Enhances Signaling by Glycogen Synthase Kinase-3β. Cancer Research. 71(4). 1334–1343. 96 indexed citations
10.
Shin, Sung‐Young, Oliver Rath, Armin Zebisch, et al.. (2010). Functional Roles of Multiple Feedback Loops in Extracellular Signal-Regulated Kinase and Wnt Signaling Pathways That Regulate Epithelial-Mesenchymal Transition. Cancer Research. 70(17). 6715–6724. 121 indexed citations
11.
Al‐Mulla, Fahd, Milad S. Bitar, Zainab J. Taqi, Oliver Rath, & Walter Kölch. (2010). RAFkinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. Molecular BioSystems. 7(3). 928–941. 39 indexed citations
12.
Vera, Julio, Oliver Rath, Eva Balsa‐Canto, et al.. (2010). Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models. Molecular BioSystems. 6(11). 2174–2191. 18 indexed citations
13.
Tcherniuk, Sergey, Dimitrios A. Skoufias, Christophe Labrière, et al.. (2010). Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin‐Specific MKLP‐2 Inhibitor. Angewandte Chemie International Edition. 49(44). 8228–8231. 50 indexed citations
14.
Kaan, Hung Yi Kristal, Venkatasubramanian Ulaganathan, Oliver Rath, et al.. (2010). Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol. Journal of Medicinal Chemistry. 53(15). 5676–5683. 132 indexed citations
15.
Nikolov, Svetoslav, Julio Vera, Oliver Rath, Walter Kölch, & Olaf Wolkenhauer. (2009). Role of inhibitory proteins as modulators of oscillations in NFκB signalling. IET Systems Biology. 3(2). 59–76. 12 indexed citations
16.
Garcia, Reynaldo L., Joan Grindlay, Oliver Rath, Frances Fee, & Walter Kölch. (2009). Regulation of human myoblast differentiation by PEBP4. EMBO Reports. 10(3). 278–284. 34 indexed citations
17.
Rath, Oliver, Sungdae Park, Mark J. Banfield, et al.. (2008). The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK. Cellular Signalling. 20(5). 935–941. 41 indexed citations
18.
Kim, Man-Sun, et al.. (2007). A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways. Oncogene. 26(31). 4571–4579. 110 indexed citations
19.
Dhillon, Amardeep S., Suzanne Hagan, Oliver Rath, & Walter Kölch. (2007). MAP kinase signalling pathways in cancer. Oncogene. 26(22). 3279–3290. 2308 indexed citations breakdown →
20.
Park, Sungdae, Oliver Rath, Sandy Beach, et al.. (2006). Regulation of RKIP binding to the N‐region of the Raf‐1 kinase. FEBS Letters. 580(27). 6405–6412. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026